A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection
Clinical trial NCT00000760 · COMPLETED
Trial details
- NCT number
- NCT00000760
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.